Press/Media
- 175 - 200 out of 3,795 results
Search results
-
Rachel E. Rau, MD, and Sumit Gupta, MD, PhD, on Pediatric B-Cell ALL: Blinatumomab Added to Chemotherapy in Newly Diagnosed Disease
10/12/24
1 item of Media coverage
Press/Media
-
Nitin Jain, MD, on First-Line Treatment With Pirtobrutinib-Based Regimen in CLL
10/12/24
1 item of Media coverage
Press/Media
-
Maayan Levy, PhD, and Marco Ruella, MD, on How a Ketogenic Diet Enhances CAR T-Cell Antitumor Function Via Beta-Hydroxybutyrate (BHB)
9/12/24
1 item of Media coverage
Press/Media
-
Novel MDM2 Inhibitor Shows Disease-Modifying Activity in R/R Myelofibrosis
9/12/24
1 item of Media coverage
Press/Media
-
Anne Sophie Michallet, MD, PhD, on MRD-Guided vs Standard Combination Therapy for Select Untreated Patients With CLL
9/12/24
2 items of Media coverage
Press/Media
-
Navtemadlin Shows Biomarker Response in Patients with R/R Myelofibrosis
8/12/24
1 item of Media coverage
Press/Media
-
Weekly: Tilray Brands (TLRY: $1.28) shares post worst week in three weeks; -6c [4.5%]
Kaplan,, S. & Sfakianos, J.
7/12/24
1 item of Media coverage
Press/Media
-
Weekly: Karyopharm Therapeutics (KPTI: 76.82c) sinks 9% on weak volume, Cash Runway of 4 months; -7.69c [9.1%]
7/12/24
1 item of Media coverage
Press/Media
-
Ajax Therapeutics to Present Overview of Phase 1 Clinical Trial Evaluating AJ1-11095
6/12/24
1 item of Media coverage
Press/Media
-
Pelabresib and Ruxolitinib Achieve Primary End Point in Phase 3 MANIFEST-2 Trial
5/12/24
1 item of Media coverage
Press/Media
-
Ajax Therapeutics to Present Overview of Phase 1 Clinical Trial Evaluating AJ1-11095
5/12/24
1 item of Media coverage
Press/Media
-
Genes highlight who will benefit from multiple myeloma therapy
4/12/24 → 5/12/24
2 items of Media coverage
Press/Media
-
Genes Highlight Who'll Benefit From Multiple Myeloma Treatment With Venclexta
4/12/24
7 items of Media coverage
Press/Media
-
Researchers from University of Texas Southwestern Medical Center Detail Findings in COVID-19 (Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed Sars-cov-2 Infections)
Hirsch, F., Hirsch, F., Bhalla, S. & Krammer, F.
4/12/24
1 item of Media coverage
Press/Media
-
Genes Highlight Who'll Benefit From Multiple Myeloma Therapy
4/12/24
45 items of Media coverage
Press/Media
-
Ajax Therapeutics to Present Overview of Phase 1 Clinical Trial Evaluating AJ1-11095
4/12/24
1 item of Media coverage
Press/Media
-
A case of adult ETV6-ASCL6 fusion gene positive chronic myeloproliferative tumor and literature review.
3/12/24
1 item of Media coverage
Press/Media
-
Tilray Brands falls 24% in past year
Kaplan,, S. & Sfakianos, J.
3/12/24
1 item of Media coverage
Press/Media
-